HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Abe Selected Research

Carcinoma (Carcinomatosis)

10/2014Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides.
6/2000Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Abe Research Topics

Disease

16Neoplasms (Cancer)
03/2015 - 01/2000
8Inflammation (Inflammations)
07/2010 - 01/2000
7Sarcoidosis (Schaumann Disease)
04/2003 - 01/2000
7Asthma (Bronchial Asthma)
09/2001 - 01/2000
6Hearing Loss (Hearing Impairment)
05/2009 - 01/2000
5Adenocarcinoma
03/2015 - 06/2000
5Interstitial Lung Diseases (Interstitial Lung Disease)
03/2013 - 03/2000
5Pulmonary Sarcoidosis
04/2003 - 06/2000
5Myocardial Infarction
11/2001 - 03/2000
4Hepatocellular Carcinoma (Hepatoma)
07/2014 - 01/2000
4Lung Diseases (Lung Disease)
12/2004 - 11/2000
4Pancreatic Neoplasms (Pancreatic Cancer)
12/2001 - 07/2000
4Thrombosis (Thrombus)
08/2001 - 08/2000
4Infections
06/2001 - 06/2000
3Pathologic Constriction (Stenosis)
07/2018 - 09/2001
3Hypertension (High Blood Pressure)
02/2011 - 08/2000
3Diabetes Mellitus
12/2006 - 08/2000
3Fibrosis (Cirrhosis)
12/2004 - 09/2000
3Weight Loss (Weight Reduction)
09/2001 - 01/2000
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2021 - 02/2001
2Carcinogenesis
10/2014 - 10/2000
2Carcinoma (Carcinomatosis)
10/2014 - 06/2000
2Acute Kidney Injury (Acute Renal Failure)
11/2009 - 08/2000
2Deafness (Deaf Mutism)
06/2006 - 01/2001
2Hypersensitivity (Allergy)
05/2005 - 01/2004
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2004 - 02/2001
2Osteosarcoma (Osteogenic Sarcoma)
10/2002 - 07/2001
2Cough
12/2001 - 07/2001
2Mycoplasma Pneumonia
09/2001 - 11/2000
2Tuberculosis (Tuberculoses)
09/2001 - 06/2000
2Pleural Effusion (Pleural Effusions)
09/2001 - 11/2000
2Chronic Hepatitis C
08/2001 - 03/2001
2Diffuse panbronchiolitis
07/2001 - 01/2000
2Lung Neoplasms (Lung Cancer)
07/2001 - 10/2000
2Breast Neoplasms (Breast Cancer)
05/2001 - 07/2000
2Hypoxia (Hypoxemia)
03/2001 - 04/2000
2Pneumonia (Pneumonitis)
02/2001 - 11/2000
2Hypertrophy
09/2000 - 08/2000
2Idiopathic Pulmonary Fibrosis
09/2000 - 02/2000
2Fever (Fevers)
06/2000 - 01/2000
1Glioma (Gliomas)
01/2018
1Astrocytoma (Pilocytic Astrocytoma)
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
03/2015
1Birth Weight (Birth Weights)
10/2014

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
06/2008 - 01/2000
6Surface-Active Agents (Surfactants)IBA
03/2013 - 03/2000
6Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
04/2001 - 03/2000
5Cisplatin (Platino)FDA LinkGeneric
07/2014 - 07/2001
5Biomarkers (Surrogate Marker)IBA
04/2003 - 03/2000
5Interleukin-18 (Interleukin 18)IBA
02/2001 - 06/2000
4AminoglycosidesIBA
05/2009 - 01/2000
4Messenger RNA (mRNA)IBA
09/2004 - 06/2000
4EnzymesIBA
08/2000 - 01/2000
3SteroidsIBA
07/2018 - 02/2001
3AntigensIBA
10/2007 - 10/2000
3Interleukin-12 (IL 12)IBA
04/2003 - 06/2000
3Thromboplastin (Tissue Factor)IBA
12/2001 - 10/2000
3Anti-Bacterial Agents (Antibiotics)IBA
11/2001 - 01/2000
3Adrenal Cortex Hormones (Corticosteroids)IBA
09/2001 - 01/2000
37-hydroxystaurosporine (UCN 01)IBA
05/2001 - 07/2000
3CytokinesIBA
01/2001 - 03/2000
3ImmunosorbentsIBA
08/2000 - 01/2000
2Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2021 - 02/2001
2MicroRNAs (MicroRNA)IBA
10/2014 - 09/2014
2Protein CIBA
03/2013 - 11/2001
2Indicators and Reagents (Reagents)IBA
12/2012 - 08/2000
2CholesterolIBA
02/2011 - 10/2000
2Coloring Agents (Dyes)IBA
09/2009 - 06/2000
2Biological ProductsIBA
09/2004 - 06/2000
2Angiotensin IIIBA
01/2004 - 08/2000
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2004 - 02/2001
2Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2004 - 03/2000
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2003 - 04/2001
2A-factor (Streptomyces)IBA
12/2001 - 04/2000
2Fibrinogen (Factor I)FDA Link
11/2001 - 10/2000
2Factor VII (Proconvertin)IBA
11/2001 - 10/2000
2Tumor Biomarkers (Tumor Markers)IBA
10/2001 - 06/2000
2Prednisolone (Predate)FDA LinkGeneric
09/2001 - 05/2001
2Interleukin-8 (Interleukin 8)IBA
09/2001 - 03/2000
2Phencyclidine (Angel Dust)IBA
08/2001 - 10/2000
2InterferonsIBA
08/2001 - 03/2001
2Erythromycin (Erycette)FDA LinkGeneric
07/2001 - 02/2001
2Styrene (Styrol)IBA
06/2001 - 01/2000
2maleic acid (maleate)IBA
06/2001 - 01/2000
2Ethiodized Oil (Ethiodol)FDA Link
06/2001 - 01/2000
2ZinostatinIBA
06/2001 - 01/2000
2Dihydrotachysterol (AT 10)IBA
05/2001 - 10/2000
2Phosphotransferases (Kinase)IBA
03/2001 - 09/2000
2MacrolidesIBA
02/2001 - 01/2000
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2001 - 10/2000
2Interferon-gamma (Interferon, gamma)IBA
11/2000 - 06/2000
2AcidsIBA
10/2000 - 01/2000
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2000 - 01/2000
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2018
1brefelamideIBA
01/2018
1Cetuximab (Erbitux)FDA Link
03/2015
1ChemokinesIBA
10/2014

Therapy/Procedure

12Therapeutics
03/2015 - 01/2000
5Drug Therapy (Chemotherapy)
01/2018 - 02/2001
3Stents
07/2010 - 12/2000